The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Prevention of recurrent preterm delivery by 17 alpha–hydroxyprogesterone caproate
Open accessAbstract
BACKGROUND: Women who have had a spontaneous preterm delivery are at greatly increased risk for preterm delivery in subsequent pregnancies. The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery. METHODS: We conducted a double-blind, placebo-controlled trial involving pregnant women with a documented history of spontaneous preterm delivery. Women were enrolled at 19 clinical centers at 16 to 20 weeks of gestation and randomly assigned by a central data center, in a 2:1 ratio, to receive either weekly injections of 250 mg of 17P or weekly injections of an inert oil placebo; injections were continued until delivery or to 36 weeks of gestation. The primary outcome was preterm delivery before 37 weeks of gestation. Analysis was performed according to the intention-to-treat principle. RESULTS: Base-line characteristics of the 310 women in the progesterone group and the 153 women in the placebo group were similar. Treatment with 17P significantly reduced the risk of delivery at less than 37 weeks of gestation (incidence, 36.3 percent in the progesterone group vs. 54.9 percent in the placebo group; relative risk, 0.66 [95 percent confidence interval, 0.54 to 0.81]), delivery at less than 35 weeks of gestation (incidence, 20.6 percent vs. 30.7 percent; relative risk, 0.67 [95 percent confidence interval, 0.48 to 0.93]), and delivery at less than 32 weeks of gestation (11.4 percent vs. 19.6 percent; relative risk, 0.58 [95 percent confidence interval, 0.37 to 0.91]). Infants of women treated with 17P had significantly lower rates of necrotizing enterocolitis, intraventricular hemorrhage, and need for supplemental oxygen. CONCLUSIONS: Weekly injections of 17P resulted in a substantial reduction in the rate of recurrent preterm delivery among women who were at particularly high risk for preterm delivery and reduced the likelihood of several complications in their infants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“however, because progesterone antagonists—such as RU486—initiate preterm labour and progestational agents prevent preterm labour, a decrease in local progesterone concentrations or in the number of receptors is a plausible mechanism for initiation of labour.16, 17, 18”
From Epidemiology and causes of preterm birth (2008) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
da Fonseca, E. B., Bittar, R. E., de Carvalho, M. H. B., & Zugaib, M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.41 · Cited by 785
Goldenberg, R. L., Iams, J. D., Mercer, B. M., Meis, P. J., Moawad, A. H., Copper, R. L., Das, A. M., Thom, E. A., Johnson, F. F., McNellis, D., et al. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.2.233 · Cited by 440
Self-citationThe Problem of Low Birth Weight
Paneth, N. (1995) · The Future of Children · doi:10.2307/1602505 · Cited by 383
Gap junction formation in myometrium: control by estrogens, progesterone, and prostaglandins
Garfield, R. E., Kannan, M., & Daniel, E. E. (1980) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1980.238.3.c81 · Cited by 353
Properties of the urn randomization in clinical trials
Wei, L. J., & Lachin, J. M. (1988) · Controlled Clinical Trials · doi:10.1016/0197-2456(88)90048-7 · Cited by 308
The Preterm Prediction Study: Recurrence risk of spontaneous preterm birth
Iams, J. D., Goldenberg, R. L., Mercer, B. M., Moawad, A., Thom, E. A., Meis, P. J., McNellis, D., Caritis, S. N., Miodovnik, M., Menard, M. K., et al. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70544-7 · Cited by 256
Self-citationProgestogen administration in pregnancy may prevent preterm delivery
Keirse, M. J. N. C. (1990) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1990.tb01740.x · Cited by 256
Efficacy of 17α-Hydroxyprogesterone Caproate in the Prevention of Premature Labor
Johnson, J. W., Austin, K., Jones, G. S., Davis, G. H., & King, T. M. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510022931401 · Cited by 224
Sharp Increase in Free Circulating Oestrogens Immediately Before Parturition in Sheep
Challis, J. R. G. (1971) · Nature · doi:10.1038/229208a0 · Cited by 222
Frequency of uterine contractions and the risk of spontaneous preterm delivery
Iams, J. D., Newman, R. B., Thom, E. A., Goldenberg, R. L., Mueller-Heubach, E., Moawad, A., Sibai, B. M., Caritis, S. N., Miodovnik, M., Paul, R. H., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa002868 · Cited by 205
Self-citationPreterm birth prevention: Where are we?
Creasy, R. K. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90373-q · Cited by 199
Fetal genital effects of first-trimester sex hormone exposure: A meta-analysis
Raman‐Wilms, L. (1995) · Obstetrics and Gynecology · doi:10.1016/0029-7844(94)00341-a · Cited by 193
Preterm delivery: a public health perspective
Mattison, D. R., Damus, K. H., Fiore, E., Petrini, J. R., & Alter, C. C. (2001) · Paediatric and Perinatal Epidemiology · doi:10.1046/j.1365-3016.2001.00004.x · Cited by 162
A meta‐analysis of randomized control trials of progestational agents in pregnancy
GOLDSTEIN, P., Berrier, J., ROSEN, S., Sacks, H. S., & Chalmers, T. C. (1989) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1989.tb02385.x · Cited by 155
The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women
Hobel, C. J., Ross, M. G., Bemis, R. L., Bragonier, J. R., Nessim, S., Sandhu, M., Bear, M. B., & Mori, B. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(94)70384-1 · Cited by 139
Congenital abnormalities and hormones during pregnancy: A clinical review
Schardein, J. L. (1980) · Teratology · doi:10.1002/tera.1420220302 · Cited by 132
Hartikainen-Sorri, A. L., Kauppila, A., & Tuimala, R. J. (1980) · PubMed · Cited by 122
Prevention of premature labor by 17α-hydroxyprogesterone caproate
Yemini, M., Borenstein, R., Dreazen, E., Appelman, Z., Mogilner, B. M., Kessler, I., & Lancet, M. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90141-3 · Cited by 106
Hauth, J. C., Gilstrap, L. C., Brekken, A. L., & Hauth, J. M. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)91051-7 · Cited by 101
Self-citationFrydman, R., Lelaidier, C., Baton, C., Fernandez, H., Vial, M. T., & Bourget, P. (1993) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(93)90660-o · Cited by 96
Treatment of threatened premature labor with large doses of progesterone
Fuchs, F., & STAKEMANN, G. (1960) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(60)90381-1 · Cited by 93
Double-Blind Trial of a Progestin in Habitual Abortion
Goldzieher, J. W. (1964) · JAMA · doi:10.1001/jama.1964.03060330031008 · Cited by 92
Progesterone Implantation in Habitual Abortion
Swyer, G. I. M., & Daley, D. (1953) · BMJ · doi:10.1136/bmj.1.4819.1073 · Cited by 86
LOCAL MODULATION OF PROGESTERONE PRODUCTION IN HUMAN FETAL MEMBRANES
Mitchell, B. F., Cruickshank, B., MCLEAN, D., & Challis, J. R. G. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-6-1237 · Cited by 57
SOME NEW THOUGHTS ON THE FETOPLACENTAL UNIT AND PARTURITION IN PRIMATES
Siiteri, P. K., & Serón‐Ferré, M. (1981) · Elsevier eBooks · doi:10.1016/b978-0-12-522601-1.50008-1 · Cited by 47
Flagged first, then by citations
Research works printed but not linked: 3
- LeVine, , L Habitual abortion: a controlled clinical study of pregestational therapy. West J Surg Obstet Gynecol 1964;72:3036-3036
- Hauth, , JC , Andrews, , WW , Goldenberg, , RL Infection-related risk factors predictive of spontaneous preterm labor and birth. Prenat Neonat Med 1998;3:86-90
- Sondergaard, , F , Ottesen, , B , Detlefsen, , G , Traitement par la progesterone des menaces d'accouchment premature avec taux bas de progesterone plasmatique. Contracept Fertil Sexual 1985;13:1227-1231
Cited by
Sorted by citations
Epidemiology and causes of preterm birth
Goldenberg, R. L., Culhane, J. F., Iams, J. D., & Romero, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60074-4 · Cited by 7,801
Self-citationPreterm labor: One syndrome, many causes
Romero, R., Dey, S. K., & Fisher, S. J. (2014) · Science · doi:10.1126/science.1251816 · Cited by 1,984
The preterm parturition syndrome
Romero, R., Espinoza, J., Kusanovic, J., Gotsch, F., Hassan, S., Erez, O., Chaiworapongsa, T., & Mazor, M. (2006) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01120.x · Cited by 1,419
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Mechanisms of implantation: strategies for successful pregnancy
Cha, J., Sun, X., & Dey, S. K. (2012) · Nature Medicine · doi:10.1038/nm.3012 · Cited by 1,391
Metadata
- Authors
- Meis, P. J., Klebanoff, M., Thom, E., Dombrowski, M. P., Sibai, B., Moawad, A. H., Spong, C. Y., Hauth, J. C., Miodovnik, M., Varner, M. W., Leveno, K. J., Caritis, S. N., Iams, J. D., Wapner, R. J., Conway, D., O'Sullivan, M. J., Carpenter, M., Mercer, B., Ramin, S. M., Thorp, J. M., Peaceman, A. M., & Gabbe, S.
- Affiliations
- Wayne State University (US)
- National Institutes of Health (US)
- University of Pittsburgh (US)
- Thomas Jefferson University (US)
- From Wake Forest University, Winston-Salem, N.C. (P.J.M.); the National Institute of Child Health and Human Development, Bethesda, Md. (M.K., C.Y.S.); the Biostatistics Center, George Washington University, Rockville, Md. (E.T.); Wayne State University, Detroit (M.P.D.); the University of Tennessee, Memphis (B.S.); the University of Chicago, Chicago (A.H.M.); the University of Alabama, Birmingham (J.C.H.); the University of Cincinnati, Cincinnati,...
- University of North Carolina at Chapel Hill (US)
- Northwestern University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-06-12
- Volume
- 348
- Issue
- 24
- Pages
- 2379-2385
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2065614074
- Cited by
- 1,555
- References
- 27
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 38 · 2023: 46 · 2022: 50 · 2021: 53 · 2020: 72 · 2019: 56 · 2018: 66 · 2017: 141 · 2016: 94 · 2015: 73 · 2014: 71 · 2013: 85 · 2012: 101
- FWCI
- 38.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (M01RR000080)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD40512, HD27905, HD27917, U10HD027861, HD-27915, HD34116, HD34136, (HD40500, HD34210, HD-21414, HD 40544, HD-27860, HD40560, HD27861, U10HD027917, U10HD027905, U10HD027860, HD 34208, HD 36801, HD34122, U10HD034210, HD27869, [HD21410, U10HD034122, U10HD034136)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Preterm Birth and Chorioamnionitis
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Development and Preterm Care
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Neonatal Respiratory Health Research
- Keywords
- 17-hydroxyprogesterone caproate, preterm birth prevention, progesterone supplementation, neonatal complications, necrotizing enterocolitis, intraventricular hemorrhage, supplemental oxygen
- MeSH terms
- 17 alpha-Hydroxyprogesterone Caproate, Adult, Birth Weight, Cerebral Hemorrhage, Double-Blind Method, Female, Humans, Hydroxyprogesterones, Infant, Newborn, Infant, Premature, Obstetric Labor, Premature, Oxygen Inhalation Therapy, Pregnancy, Pregnancy Outcome, Risk, Survival Analysis, Enterocolitis, Necrotizing, Progesterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review